What the diagnosis actually covers

Persistent shoulder pain that won't settle after a few weeks is one of the most common reasons people seek an MSK opinion — and supraspinatus tendinopathy is the most frequent explanation, accounting for the majority of shoulder pain presentations and ranking as the third most common musculoskeletal complaint overall, behind low back pain and knee pain.

The term is not a single diagnosis. It groups three distinct conditions under one label: tendinitis, in which the tendon is acutely inflamed; tendinosis, a degenerative change in tendon structure without significant inflammation; and a partial-thickness tear, where some tendon fibres have broken down. The starting point for treatment differs across these three — early-stage loading protocols, anti-inflammatory strategies, and rehabilitation timelines are all calibrated differently depending on which is present.

A scan alone cannot settle which sub-type is involved. Ultrasound and MRI show tendon structure, but the same pain location can reflect tendon overload, a partial tear, referred pain, joint disease, or nerve irritation. Correct diagnosis depends on combining imaging with a thorough clinical examination and a detailed history of how, when, and under what loads the pain developed. An imaging report showing tendon change is a prompt for assessment — not a verdict in itself.

Why no single specialty 'owns' this condition

The number of specialties involved in managing this condition can feel confusing from the outside. The explanation is straightforward: the staged nature of care means different clinicians are most relevant at different points in the pathway, and no single specialty has exclusive ownership.

Physiotherapists lead first-line management. Isometric exercise in the early phase, progressing to eccentric loading as the tendon tolerates more stress, is the dominant approach across international guidelines and clinical practice. Most patients with supraspinatus tendinopathy are managed entirely in an outpatient physiotherapy setting and do not require onward referral.

When first-line rehabilitation has not produced adequate improvement, or when a corticosteroid or other injection is being considered, sports medicine physicians, rheumatologists, and interventional MSK specialists take a more prominent role. These clinicians are trained to combine injection-based and advanced physical therapies — including extracorporeal shockwave therapy — with supervised rehabilitation.

Orthopaedic shoulder surgeons are appropriate when conservative options have genuinely been exhausted and structural repair is indicated. One important clarification from current guidelines: acromioplasty — surgical shaving of the bone above the tendon — is not recommended as a standalone management strategy.

Understanding where each specialty sits in this sequence makes it easier to ask the right questions at a first appointment: how far along the pathway am I, and what is the appropriate next step given what has already been tried?

What a thorough first assessment should include

A good assessment starts well before any scan. The clinical foundation is a detailed load history — which movements provoke pain, whether onset was sudden or gradual, what occupational or sporting demands the shoulder is under, and what has already been tried. A traumatic onset, significant strength loss, or night pain each alter the clinical picture in ways that change the management pathway; a specialist will typically ask about all of these.

Clinical examination should cover more than range of motion and basic strength tests. Scapular dyskinesia — altered movement of the shoulder blade — is frequently missed in standard assessments yet may be both a cause and a consequence of supraspinatus tendinopathy. When the scapula does not move as it should, the mechanics of the entire shoulder complex are disrupted, placing abnormal loads on the tendon over time. Asking whether scapular control has been specifically assessed is a reasonable question at any first appointment.

Where imaging is requested, its value is additive rather than decisive. Ultrasound can confirm tendon structure, identify calcific deposits, and detect partial tears; MRI adds detail on tear extent and associated joint changes. Importantly, these findings help determine which sub-type is present — inflammatory tendinitis, degenerative tendinosis, or a partial-thickness tear — and that distinction directly shapes the emphasis of treatment that follows.

Treatment options at each stage of the pathway

Regardless of how long symptoms have been present, exercise rehabilitation is the non-negotiable starting point. The progression follows a consistent pattern: isometric loading first — muscle contractions without joint movement — to reduce pain with minimal tendon stress; then a gradual shift towards eccentric and functional movements as tolerance improves. This framework applies across all sub-types, though the pace of progression is calibrated to the individual and reassessed regularly.

When symptoms persist or early pain control is needed, a corticosteroid injection combined with physiotherapy may offer short-term relief. A systematic review found this combination can produce small to moderate improvements in pain and function over physiotherapy alone in the short term — but the advantage does not hold at longer follow-up. Corticosteroid alone, without concurrent rehabilitation, is not more effective than exercise.

Extracorporeal shockwave therapy (ESWT) is a substantive non-surgical option worth discussing if first-line rehabilitation has not yielded adequate improvement. ESWT delivers focused acoustic energy to the tendon without incisions or needles. A randomised controlled trial found it significantly more effective than deep friction massage for pain and shoulder abduction, with large effect sizes. In a separate observational study of 39 patients with non-calcific supraspinatus tendinopathy, three sessions over three weeks produced sustained improvements in pain scores and shoulder function at six months.

Platelet-rich plasma (PRP) has attracted clinical interest but remains inconsistent across trials. Current evidence suggests any benefit may be limited to inflammatory tendinopathy where the tendon is structurally intact; there is no consensus supporting routine use.

Hyaluronic acid showed greater short-term improvement in pain, range of motion, and quality of life than physiotherapy alone at three months in one review — but the certainty of that evidence was rated as very low.

Surgery enters the discussion only when conservative options have been genuinely exhausted and structural repair is indicated — it is an end-stage decision, not a default.

Honest recovery expectations

Recovery from supraspinatus tendinopathy takes longer than most patients expect — and honest data is more useful than optimism at the outset. Around 47% of people recover within 12 months, with median recovery falling at approximately month seven. That means roughly half of patients are still working through the condition a year after it began.

Being moderately physically active and having higher baseline health status are both associated with a better recovery course. Pain severity at the outset, and demographic factors such as age or sex, do not reliably predict who recovers — so neither a high pain score nor a low one tells a clinician much about likely trajectory.

These figures are not a reason for pessimism. Supraspinatus tendinopathy is manageable; slow recovery is not the same as no recovery. What they do signal is that a realistic timeline — and a plan for what to review and when — matters as much as the initial treatment choice. Three months is a reasonable checkpoint to assess whether first-line rehabilitation is gaining ground; if progress has stalled by month five or six, that is a clear trigger to revisit the pathway rather than continue indefinitely with the same approach. At a first appointment, asking directly for a prognostic estimate — not just a treatment plan — is entirely reasonable, and a clinician who engages with it honestly is better placed to support genuine planning.

Questions worth raising at your first appointment

A 2026 qualitative study found that patients with rotator cuff tendinopathy most often felt unheard — they wanted their pain acknowledged and to be included in decisions about their care, not handed a leaflet and sent away. That context is worth holding onto before an appointment: the questions below are not demands, but they are reasonable starting points for a conversation that actually moves things forward.

Which sub-type has been identified? Tendinitis, tendinosis, and partial tears each carry different management priorities. If the label remains "supraspinatus tendinopathy" without further specification, it is fair to ask how the distinction is being made and whether that changes the treatment approach.

Has scapular control been assessed? Altered scapulothoracic movement can both cause and perpetuate tendon overload, and is frequently missed without a targeted examination. If nobody has looked at it yet, the question is entirely warranted.

Is shockwave therapy an option? If exercise rehabilitation has produced insufficient progress, ESWT is a well-evidenced non-surgical escalation worth raising before assuming injection is the only next step.

What does a realistic recovery look like — and when would you change course? Having the clinician name a specific review point and commit to a plan if progress stalls turns a treatment plan into a genuine management strategy, which is what the recovery data supports.

For patients still deciding where to begin, Search MSK lists practitioners across the UK who manage rotator cuff conditions — a way to compare specialists by region and specialty before committing to a first appointment.